Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Thermo Fisher ( (TMO) ) has shared an update.
On September 2, 2025, Thermo Fisher Scientific completed its $4.0 billion acquisition of Solventum Corporation’s purification and filtration business, enhancing its bioprocessing and adjacent market offerings. The acquisition is expected to generate $750 million in revenue for 2025 and provide significant growth and synergy opportunities, although it will initially be dilutive to adjusted EPS by $0.06. The transaction strengthens Thermo Fisher’s portfolio with advanced filtration technologies, expanding its reach in industries requiring ultra-pure water, such as battery, semiconductor, and medical device manufacturing.
The most recent analyst rating on (TMO) stock is a Buy with a $557.00 price target. To see the full list of analyst forecasts on Thermo Fisher stock, see the TMO Stock Forecast page.
Spark’s Take on TMO Stock
According to Spark, TipRanks’ AI Analyst, TMO is a Outperform.
Thermo Fisher’s overall stock score is driven by its strong financial performance and positive earnings call, which highlight robust operational execution and strategic growth initiatives. While technical indicators show bullish momentum, valuation concerns due to a high P/E ratio and low dividend yield temper the outlook.
To see Spark’s full report on TMO stock, click here.
More about Thermo Fisher
Thermo Fisher Scientific Inc. is a global leader in serving science, with annual revenues exceeding $40 billion. The company provides innovative technologies, purchasing convenience, and pharmaceutical services through its industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher supports customers in accelerating life sciences research, solving analytical challenges, improving laboratory productivity, enhancing patient health through diagnostics, and developing life-changing therapies.
Average Trading Volume: 2,638,100
Technical Sentiment Signal: Buy
Current Market Cap: $186.1B
For a thorough assessment of TMO stock, go to TipRanks’ Stock Analysis page.